C07D455/00

Compositions and methods for making terpenoid indole alkaloids
11072613 · 2021-07-27 · ·

Methods that may be used for the manufacture of a class of chemical compounds known as terpenoid indole alkaloids, including tabersonine and catharanthine are provided. Compositions useful for the synthesis of terpenoid indole alkaloids, including tabersonine and catharanthine are also provided. The provided compounds are useful in the manufacture of chemotherapeutic agents.

Compositions and methods for making terpenoid indole alkaloids
11072613 · 2021-07-27 · ·

Methods that may be used for the manufacture of a class of chemical compounds known as terpenoid indole alkaloids, including tabersonine and catharanthine are provided. Compositions useful for the synthesis of terpenoid indole alkaloids, including tabersonine and catharanthine are also provided. The provided compounds are useful in the manufacture of chemotherapeutic agents.

COMPOSITIONS AND METHODS FOR MAKING TERPENOID INDOLE ALKALOIDS
20200002339 · 2020-01-02 ·

Methods that may be used for the manufacture of a class of chemical compounds known as terpenoid indole alkaloids, including tabersonine and catharanthine are provided. Compositions useful for the synthesis of terpenoid indole alkaloids, including tabersonine and catharanthine are also provided. The provided compounds are useful in the manufacture of chemotherapeutic agents.

COMPOSITIONS AND METHODS FOR MAKING TERPENOID INDOLE ALKALOIDS
20200002339 · 2020-01-02 ·

Methods that may be used for the manufacture of a class of chemical compounds known as terpenoid indole alkaloids, including tabersonine and catharanthine are provided. Compositions useful for the synthesis of terpenoid indole alkaloids, including tabersonine and catharanthine are also provided. The provided compounds are useful in the manufacture of chemotherapeutic agents.

NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE
20240246965 · 2024-07-25 · ·

The present invention relates compounds of general formula (I)

##STR00001##

and stereoisomers and pharmaceutically acceptable salts thereof; wherein R.sup.1, R.sup.2, R.sup.7, R.sup.a, R.sup.b, R.sup.c, and the dotted line is as defined in the claims. The invention also relates to pharmaceutical compositions comprising a compound of formula (I) and to said compounds for use as a medicament and particularly in the treatment or prevention of drug addiction and CNS related diseases and conditions. Further, the invention relates to methods for the preparation of a compound of formula (I), or pharmaceutically acceptable salt or a stereoisomer thereof.

NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE
20240246965 · 2024-07-25 · ·

The present invention relates compounds of general formula (I)

##STR00001##

and stereoisomers and pharmaceutically acceptable salts thereof; wherein R.sup.1, R.sup.2, R.sup.7, R.sup.a, R.sup.b, R.sup.c, and the dotted line is as defined in the claims. The invention also relates to pharmaceutical compositions comprising a compound of formula (I) and to said compounds for use as a medicament and particularly in the treatment or prevention of drug addiction and CNS related diseases and conditions. Further, the invention relates to methods for the preparation of a compound of formula (I), or pharmaceutically acceptable salt or a stereoisomer thereof.

Substituted quinolizine derivatives useful as HIV integrase inhibitors

The present invention relates to Substituted Quinolizine Derivatives of Formula (I): ##STR00001##
and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.9 and R.sup.10 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.

Substituted quinolizine derivatives useful as HIV integrase inhibitors

The present invention relates to Substituted Quinolizine Derivatives of Formula (I): ##STR00001##
and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.9 and R.sup.10 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.

Opioid analgesic

Provided are a compound represented by formula (I) or (II), a salt thereof, or solvates of the compound and salt, having an analgesic effect and high metabolic stability. Further provided are the following: an analgesic obtained from the compound, a salt thereof, or solvates of the compound and salt; a pharmaceutical composition containing the compound, a salt thereof, or solvates of the compound and salt; an analgesic treatment method using the compound, a salt thereof, or solvates of the compound and salt; and a use of the compound, a salt thereof, or solvates of the compound and salt, in the production of an analgesic composition.

Opioid analgesic

Provided are a compound represented by formula (I) or (II), a salt thereof, or solvates of the compound and salt, having an analgesic effect and high metabolic stability. Further provided are the following: an analgesic obtained from the compound, a salt thereof, or solvates of the compound and salt; a pharmaceutical composition containing the compound, a salt thereof, or solvates of the compound and salt; an analgesic treatment method using the compound, a salt thereof, or solvates of the compound and salt; and a use of the compound, a salt thereof, or solvates of the compound and salt, in the production of an analgesic composition.